CME Group (CME) Stock Forecast & Price Target $261.44 -0.80 (-0.31%) As of 03:28 PM Eastern Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CME Group - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating HoldBased on 16 Analyst RatingsSell4Hold8Buy4 Based on 16 Wall Street analysts who have issued ratings for CME Group in the last 12 months, the stock has a consensus rating of "Hold." Out of the 16 analysts, 4 have given a sell rating, 8 have given a hold rating, 3 have given a buy rating, and 1 has given a strong buy rating for CME. Consensus Price Target $241.53-7.61% Downside According to the 16 analysts' twelve-month price targets for CME Group, the average price target is $241.53. The highest price target for CME is $287.00, while the lowest price target for CME is $187.00. The average price target represents a forecasted downside of -7.61% from the current price of $261.44. Get the Latest News and Ratings for CME and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CME Group and its competitors. Enter your email to sign up for newsletter Sign Up CME Analyst Ratings Over TimeTypeCurrent Forecast4/2/24 to 4/2/251 Month Ago3/3/24 to 3/3/253 Months Ago1/3/24 to 1/2/251 Year Ago4/3/23 to 4/2/24Strong Buy1 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy3 Buy rating(s)3 Buy rating(s)4 Buy rating(s)4 Buy rating(s)Hold8 Hold rating(s)8 Hold rating(s)7 Hold rating(s)4 Hold rating(s)Sell4 Sell rating(s)4 Sell rating(s)4 Sell rating(s)2 Sell rating(s)Consensus Price Target$241.53$236.13$229.33$217.30Forecasted Upside-7.61% Downside-8.08% Downside-1.46% Downside1.16% UpsideConsensus RatingHoldReduceHoldHold Remove Ads CME Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CME Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table CME Group Stock vs. The CompetitionTypeCME GroupFinance CompaniesS&P 500Consensus Rating Score 2.06 2.53 2.54Consensus RatingHoldModerate BuyModerate BuyPredicted Upside-8.89% Downside48.87% Upside19.02% UpsideNews Sentiment RatingPositive NewsSee Recent CME NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails4/2/2025Bank of America3 of 5 starsCraig SiegenthalerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetUnderperform ➝ Underperform$200.00 ➝ $219.00-16.64%3/17/2025Erste Group Bank3 of 5 starsH. EngelSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy3/10/2025Raymond James4 of 5 starsPatrick O'ShaughnessySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$287.00+12.74%2/19/2025Morgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingMike CyprysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetEqual Weight ➝ Equal Weight$256.00 ➝ $263.00+6.11%2/14/2025Keefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingKyle VoigtSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetMarket Perform ➝ Market Perform$256.00 ➝ $257.00+3.64%2/13/2025OppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingOwen LauSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOutperform ➝ Outperform$258.00 ➝ $269.00+7.59%2/13/2025Royal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingA. SabadraSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetSector Perform ➝ Sector Perform$235.00 ➝ $269.00+7.59%2/13/2025JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingKenneth WorthingtonSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetUnderweight ➝ Underweight$209.00 ➝ $212.00-15.54%2/13/2025BarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBenjamin BudishSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetEqual Weight ➝ Equal Weight$257.00 ➝ $263.00+5.64%1/7/2025Piper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$250.00 ➝ $258.00+14.25% Get the Latest News and Ratings for CME and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter. 1/6/2025CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingC. AllenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$255.00 ➝ $250.00+7.53%11/11/2024Deutsche Bank AktiengesellschaftSubscribe to MarketBeat All Access for the recommendation accuracy rating Lower TargetHold ➝ Hold$227.00 ➝ $226.00-0.14%10/8/2024Redburn AtlanticSubscribe to MarketBeat All Access for the recommendation accuracy ratingS. ClinchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$244.00+10.04%10/3/2024The Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetSell ➝ Sell$195.00 ➝ $198.00-11.89%9/26/2024TD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingW. KatzSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageHold$221.00+1.60%4/25/2024Rosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingSell ➝ Sell$185.00 ➝ $187.00-12.04%3/6/2024ArgusSubscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetBuy ➝ Buy$225.00 ➝ $245.00+12.27%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 03:43 PM ET. Should I Buy CME Group Stock? CME Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, March 29, 2025. Please send any questions or comments about these CME Group pros and cons to contact@marketbeat.com. CME Group Bull Case Here are some ways that investors could benefit from investing in CME Group Inc.: The current stock price of CME Group Inc. is $262.22, reflecting strong market performance and investor interest. CME Group Inc. reported a net margin of 57.52%, indicating high profitability and efficient cost management, which can lead to better returns for investors. Institutional investors own approximately 87.75% of CME Group Inc., suggesting strong confidence from large financial entities in the company's future performance. Recent earnings results showed an EPS of $2.52, exceeding analysts' expectations, which can signal positive growth potential and attract more investors. Analysts have given CME Group Inc. an average rating of "Hold" with a price target of $238.93, indicating that while there may be some caution, the stock is still viewed as a stable investment option. CME Group Bear Case Investors should be bearish about investing in CME Group Inc. for these reasons: JPMorgan Chase & Co. has rated CME Group Inc. as "underweight," suggesting that they believe the stock may not perform as well as others in the market. Insider selling activity has been noted, with significant shares sold by executives, which can sometimes indicate a lack of confidence in the company's future performance. The stock has a relatively high P/E ratio of 27.12, which may suggest that it is overvalued compared to its earnings, potentially leading to a price correction. Despite a strong market cap of $94.49 billion, the stock's price-to-earnings-growth ratio of 6.76 indicates that growth may not be keeping pace with its valuation, which could deter some investors. With four analysts rating the stock as a sell, there is a notable level of skepticism about its short-term performance, which could influence investor sentiment negatively. CME Forecast - Frequently Asked Questions What is CME Group's forecast for 2025? According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for CME Group is $241.53, with a high forecast of $287.00 and a low forecast of $187.00. Should I buy or sell CME Group stock right now? 16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 4 sell ratings, 8 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares. Does CME Group's stock price have much downside? According to analysts, CME Group's stock has a predicted downside of -7.61% based on their 12-month stock forecasts. Has CME Group been upgraded or downgraded by Wall Street analysts recently? Over the previous 90 days, CME Group's stock had 2 upgrades and 1 downgrade by analysts. What analysts cover CME Group? CME Group has been rated by research analysts at Bank of America, Barclays, Citigroup, Erste Group Bank, JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Oppenheimer, Piper Sandler, Raymond James, and Royal Bank of Canada in the past 90 days. Do Wall Street analysts like CME Group more than its competitors? Analysts like CME Group less than other "finance" companies. The consensus rating for CME Group is Hold while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how CME compares to other companies. Stock Forecasts and Research Tools Related Companies Intercontinental Exchange Stock Forecast Moody's Stock Forecast Interactive Brokers Group Stock Forecast MSCI Stock Forecast Nasdaq Stock Forecast MarketAxess Stock Forecast Arrow Financial Stock Forecast Tradeweb Markets Stock Forecast LPL Financial Stock Forecast Cboe Global Markets Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:CME) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CME Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CME Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CME Stock Free CME Stock Alerts